Back to Search
Start Over
Molecular imaging using PET for breast cancer.
- Source :
-
Breast cancer (Tokyo, Japan) [Breast Cancer] 2016 Jan; Vol. 23 (1), pp. 24-32. Date of Electronic Publication: 2015 Apr 28. - Publication Year :
- 2016
-
Abstract
- Molecular imaging can visualize the biological processes at the molecular and cellular levels in vivo using certain tracers for specific molecular targets. Molecular imaging of breast cancer can be performed with various imaging modalities, however, positron emission tomography (PET) is a sensitive and non-invasive molecular imaging technology and this review will focus on PET molecular imaging of breast cancer, such as FDG-PET, FLT-PET, hormone receptor PET, and anti-HER2 PET.
- Subjects :
- Bevacizumab
Breast Neoplasms metabolism
Carcinoma, Ductal, Breast metabolism
Cetuximab
Dideoxynucleosides
ErbB Receptors metabolism
Female
Fluorine Radioisotopes
Fluorodeoxyglucose F18
Humans
Norprogesterones
Receptor, ErbB-2 metabolism
Receptor, IGF Type 1 metabolism
Receptors, Estrogen metabolism
Receptors, Progesterone metabolism
Receptors, Vascular Endothelial Growth Factor metabolism
Trastuzumab
Breast Neoplasms diagnostic imaging
Carcinoma, Ductal, Breast diagnostic imaging
Molecular Imaging methods
Positron-Emission Tomography methods
Radiopharmaceuticals
Subjects
Details
- Language :
- English
- ISSN :
- 1880-4233
- Volume :
- 23
- Issue :
- 1
- Database :
- MEDLINE
- Journal :
- Breast cancer (Tokyo, Japan)
- Publication Type :
- Academic Journal
- Accession number :
- 25917108
- Full Text :
- https://doi.org/10.1007/s12282-015-0613-z